Company Overview and News
The Schwere Transporthubschrauber (STH) replacement programme for the Luftwaffe’s ageing VFW-Sikorsky CH-53G-series helicopters is soon to enter into its realisation phase, with the request for proposals (RFP) set to be issued in May.
Facebook (FB) is set to report its first-quarter earnings after the bell on Wednesday. Zuckerberg will then field questions on a conference call with analysts for the first time since the Cambridge Analytica data scandal upended the company and shaved tens of billions of dollars off its market value.
While investors in Tata Consultancy Services’ (TCS) stock celebrated the company's feat of achieving a market capitalisation of USD 100 billion, the company found something else to add to its cheer.
BERLIN (Reuters) - The German Defense Ministry plans to spend billions of euros on armaments this year to tackle deficiencies in the armed forces’ equipment, German newspaper Handelsblatt reported on Sunday.
The U.S. Air Force is investigating why an F-22 Raptor skidded to a stop on the runway at Naval Air Station Fallon in Nevada shortly after takeoff last week.The Lockheed Martin [LMT]-built F-22, which is assigned to the 90th Fighter Squadron at Joint Base Elmendorf-Richardson…
Rising interest rates and inflation worries could hang over the stock market in the coming week, as investors look to a big flood of earnings news to lift some of their anxiety.
Lockheed Martin Corp. (LMT - Free Report) is set to release first-quarter 2018 results on Apr 24, before the opening bell. In the prior quarter, the company reported a positive earnings surprise of 5.91%. Lockheed Martin has outperformed the Zacks Consensus Estimate in three of the trailing four quarters, the average positive surprise being 4.62%. Let's see how things are shaping up prior to this announcement.
In the early stages of an uptrend, it’s hard to tell just how far a stock will rally. Sometimes these trends are short-lived and “only” give us a 10% return. Other times though, these trends are good for several years and return 100% or more.
BEIJING—Lockheed Martin plans to offer Japan a fighter design that combines features of the F-22 Raptor and F-35 Lightning, Reuters reports, citing two sources with direct knowledge of the ...
General Electric – GE beat estimates with adjusted quarterly profit of 16 cents per share, 5 cents a share above estimates, with revenue also beating forecasts. CEO John Flannery said GE is seeing signs of progress in its performance, with aviation, health care, and transportation all growing. Flannery does say that conditions in the power industry are still challenging.
U.S. defense contractor Lockheed Martin plans to offer Japan a stealth fighter design based on its export-banned F-22 Raptor and advanced F-35 Lightning II aircraft, two sources said.
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...
2018-04-12 - Asif
Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...
as of ET